Search Results
Dec 11, 2025, 08:30 ET NURSE CAPITAL INVESTS IN MEDICAL DEVICE STARTUP DEVELOPING NURSE-LED INNOVATIONS IN PATIENT CARE
staff with more efficiency, convenience and time savings."Nurses don't just see problems—they engineer solutions that work," said Beth A. Brooks, PhD, RN, FACHE, Co-Founder of Nurse Capital. "Because nurses live the clinical realities day after day, their innovations are immediately usable and quickly
More news about: Nurse Capital
Dec 11, 2025, 08:30 ET CENTURY LITHIUM HIGHLIGHTS RARE EARTH POTENTIAL AT ANGEL ISLAND, NEVADA
centurylithium.com. ON BEHALF OF CENTURY LITHIUM CORP.WILLIAM WILLOUGHBY, PhD., PEPresident & Chief Executive OfficerNEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY
More news about: Century Lithium Corp.
Dec 11, 2025, 08:09 ET Indivumed und University of Rochester Medical Center intensivieren ihre Zusammenarbeit für die patientenzentrierte Entwicklung neuartiger Krebstherapien
Krebstherapie, um den Prozess der pharmazeutischen Entwicklung zu beschleunigen und gleichzeitig Risiken zu minimieren.Hartmut „Hucky" Land, PhD, stellvertretender Direktor des Wilmot Cancer Institute, freut sich auf die Zusammenarbeit: „Wir haben in der Vergangenheit bereits erfolgreich mit Indivumed
More news about: Indivumed GmbH
Dec 11, 2025, 08:00 ET HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
Time: 11 December 2025 / 11:45 – 12:45 GMTLocation: Whittle Room, Queen Elizabeth II Centre, LondonPresenter: Alvin Luk, PhD, MBA, CCRA - President & CMO (Group) and CEO (U.S.A.), TIME100 Health 2025 Honoree"For nearly a decade, CD47 therapies were held back
More news about: HanchorBio Inc.
Dec 11, 2025, 07:30 ET TuHURA Biosciences Provides Corporate Update Following Recent Financing
at Washington University School of Medicine in St. Louis; Kevin Lin, MD, PhD Student, Developmental, Regenerative, and Stem Cell Biology Program at the Washington University in St. Louis; and Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, Division of Hematology and Oncology at Vanderbilt
More news about: TuHURA Biosciences, Inc.
Dec 11, 2025, 07:00 ET New study of IBX data finds that using NeuroFlow's digital platform to connect patients to behavioral health speeds up access to care, improves outcomes, and reduces costs
integrating a digital platform with care navigation into primary care could change access to behavioral health services," said Aaron Smith-McLallen, PhD, director of Data Science and Health Outcomes at Independence Blue Cross and senior author on the study. "From January 2021 and July 2023, we studied
More news about: Independence Blue Cross
Dec 11, 2025, 06:57 ET eMerge Americas Announces First 2026 eMerge Americas Keynote Speakers
Graduating from the University of Colorado Boulder at 18 with a BA in Biochemistry, Dr. Oshmyansky went on to earn his MD from Duke and a PhD in Mathematics from Oxford as a Marshall Scholar. He completed his surgical internship at Brigham and Women's Hospital/Harvard Medical School, followed
More news about: eMerge Americas
Dec 11, 2025, 05:30 ET Cognizant Unveils Artificial Intelligence Lab and Cognizant Moment™ Studio in Bengaluru
technology and a robust partner ecosystem to transform visionary ideas into intelligent platforms and immersive experiences. The lab's team comprising PhD-level scientists and AI engineers will advance applied research in multi-agent AI, decisioning systems and responsible AI. It will also strengthen Cognizant's
More news about: Cognizant Technology Solutions Corporation
Dec 11, 2025, 05:30 ET Cognizant Unveils Artificial Intelligence Lab and Cognizant Moment™ Studio in Bengaluru
technology and a robust partner ecosystem to transform visionary ideas into intelligent platforms and immersive experiences. The lab's team comprising PhD-level scientists and AI engineers will advance applied research in multi-agent AI, decisioning systems and responsible AI. It will also strengthen Cognizant's
More news about: Cognizant Technology Solutions Corporation
Dec 11, 2025, 03:03 ET India's Future Innovators to Converge at BML Munjal University for Heroes of Tomorrow Finale
(Hons) Liberal Arts, BBA, BCom (Hons), BA LLB (Hons), BBA LLB (Hons), BBA-MBA, Integrated Programme, B. Tech at the undergraduate level, and MBA, LLB and PhD at the postgraduate level.For more details, log in to https://www.bmu.edu.in/ Photo:
More news about: BML Munjal University
Dec 10, 2025, 15:08 ET Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer
observed systemic toxicity."We are incredibly pleased to begin dosing patients with PRV131 in this first-in-human study," said Dr. Manijeh Goldberg, PhD, Founder and CEO of Privo Technologies. "Patients with oral cavity cancer often face invasive surgeries that can dramatically affect their ability to
More news about: Privo Technologies
Dec 10, 2025, 14:54 ET Hope, Made Here: LMU Inaugurates President Thomas Poon, Ph.D.
download multimedia:https://www.prnewswire.com/news-releases/hope-made-here-lmu-inaugurates-president-thomas-poon-phd-302638420.htmlSOURCE
More news about: Loyola Marymount University
Dec 10, 2025, 14:36 ET Indivumed et le Centre médical de l'Université de Rochester renforcent leur collaboration pour la découverte de nouvelles thérapies centrées sur le patient
d'identification, de validation, de criblage de ligands et de développement de cibles moléculaires pharmaceutiques contre le cancer.Hartmut « Hucky » Land, PhD, directeur adjoint du Wilmot Cancer Institute, se réjouit de cette collaboration : « Nous avons déjà travaillé avec succès avec Indivumed par le passé
More news about: Indivumed GmbH
Dec 10, 2025, 14:10 ET A Indivumed e o Centro Médico da Universidade de Rochester ampliam a colaboração para a descoberta de novas terapias centradas no paciente
do processo de identificação, validação, triagem de ligantes e desenvolvimento de alvos de câncer molecular farmacêutico.Hartmut "Hucky" Land, PhD, vice-diretor do Instituto de Câncer Wilmot, está ansioso pela colaboração: "Trabalhamos com a Indivumed com sucesso no passado e nossa familiaridade
More news about: Indivumed GmbH
Dec 10, 2025, 14:00 ET APTA Releases New Workforce and Income Data, Highlighting Growth, Demand, and Opportunities in Physical Therapy
demand, and making meaningful progress, yet still facing critical challenges that require continued focus," said APTA President Kyle Covington, PT, DPT, PhD. "By providing the physical therapy community with clear, actionable data, we can more effectively advocate for fair payment, strengthen and diversify
More news about: American Physical Therapy Association
Dec 10, 2025, 14:00 ET For A Bright Future Foundation Announces 2025 Healthcare Scholarship Recipients
valedictorian, has worked extensively in HIV advocacy and education, particularly among marginalized youth in the Philippines. She aims to pursue a PhD and lead research addressing stigma and treatment access."To be receiving a scholarship supporting healthcare students makes me feel seen and
More news about: Louis Hernandez Jr.'s Foundation For A Bright Future
Dec 10, 2025, 11:01 ET Joe Albe, Ph.D., joins Washington Research Foundation as manager of grants and venture research
multimedia:https://www.prnewswire.com/news-releases/joe-albe-phd-joins-washington-research-foundation-as-manager-of-grants-and-venture-research-302637731.htmlSOURCE
More news about: WASHINGTON RESEARCH FOUNDATION
Dec 10, 2025, 10:00 ET IBHS findings on LA County's Palisades and Eaton Fires reinforce systems-based mitigation dramatically improves home outcomes during wildfires
features."When we walk through these neighborhoods after a wildfire, the story of how the damage unfolded becomes unmistakable," said Murray Morrison, PhD, managing director of research at IBHS. "Wildfire doesn't sweep through in a perfect line; it finds weak spots, one by one. These damage patterns allow
More news about: Insurance Institute for Business & Home Safety
Dec 10, 2025, 09:30 ET Annals of Family Medicine: New Studies Tie Long-Term Primary Care Relationships to Fewer Acute Hospitalizations and Deeper Physician Trust
StudyKerry Uebel, PhD, BScMed, MBBS, MFamMed; Faith R. Yong, PhD, BPharm(Hons), MPS, AcSHP, MSHP; Maria Agaliotis, PhD, MPH, BSocSci, BNurs; Thanya Pathirana, PhD, MPH, MBBS; John D. T. Nguyen, BMed, MD; Christopher Chan; Alexandra Hawkey, PhD, MPH; Sundresan Naicker, PhD; and Kylie Vuong, PhD, MIPH, MBBSAnnals
More news about: Annals of Family Medicine
Dec 10, 2025, 09:00 ET NEW RESEARCH SHOWS RO HELPS PATIENTS ACHIEVE WEIGHT LOSS AND SAFETY OUTCOMES CONSISTENT WITH CLINICAL TRIALS
study, conducted by Ro in close collaboration with its clinical advisors, leading researchers Dr. Beverly Tchang, MD and Professor David B. Allison, PhD, evaluated outcomes among patients treated with semaglutide who also had access to Ro's comprehensive obesity care offering. This includes ongoing clinician
More news about: Ro
Dec 10, 2025, 09:00 ET Transformative Biotech Appoints Industry Veteran Kevin Kraus as CEO
Transformative Biotech for its next stage of growth and global impact," said Blomquist. "We are deeply grateful to Russ Hullet and Barbara Handelin, PhD, who have provided dedicated leadership as co-CEOs and guided the company through critical early development and advancing our patent portfolio. We look
More news about: Transformative Biotech, LLC
Dec 10, 2025, 08:00 ET Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
the process of identification, validation, ligand screening, and development of pharmaceutical molecular cancer targets.Hartmut "Hucky" Land, PhD, Deputy Director of the Wilmot Cancer Institute, is looking forward to the collaboration: "We have worked with Indivumed successfully in the past and
More news about: Indivumed GmbH
Dec 10, 2025, 08:00 ET Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
the process of identification, validation, ligand screening, and development of pharmaceutical molecular cancer targets.Hartmut "Hucky" Land, PhD, Deputy Director of the Wilmot Cancer Institute, is looking forward to the collaboration: "We have worked with Indivumed successfully in the past and
More news about: Indivumed GmbH
Dec 10, 2025, 07:45 ET Publication in Nature's Scientific Reports Reinforces Spiderwort Biotechnologies' Cellulose-Based Platform with New Findings on Neural Repair and Motor Recovery
applications.""Spinal cord injury remains one of the most challenging conditions in neurosurgery and neuroscience." Dr. Eve Tsai, MD, PhD, FRCSC, CIP., "Studies like this help grow our knowledge of potential pathways for tissue repair.""Spinal cord injury is one of the most devastating
More news about: Spiderwort Biotechnologies Inc.
Dec 10, 2025, 07:00 ET Consumers report feeling lighter, more motivated, mindful, and happier with Montoloeder's Metabolaid® weight-control formulation
Metabolaid®'s wellness benefits, we felt a consumer study would provide insights into the consumers perceptions of the product," informs Jonathan Jones, PhD, Chief R&D Officer for Monteloeder. "From their feedback we discovered Metabolaid®'s potential to support individuals along their weight-management
More news about: Monteloeder, S.L.